default author photo

Hiroshi Ishii

Fukuoka University Chikushi Hospital

Japan

  • Fukuoka University Chikushi Hospital

SCHOLARLY PAPERS

1

DOWNLOADS

145

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Atezolizumab with Carboplatin Plus Nab-Paclitaxel Combination Therapy for TTF-1 Negative Advanced Nonsquamous Non–Small Cell Lung Cancer: A Multicenter, Single-Arm Phase 2 Trial (F1NE TUNE, LOGiK 2102)

Number of pages: 22 Posted: 16 Jul 2025
Yoshimasa Shiraishi, Takayuki Shimose, Motoko Tachihara, Yuko Tsuchiya-Kawano, Ryotaro Morinaga, Hiroyuki Inoue, Yukihiro Toi, Tadaaki Yamada, Masafumi Yamaguchi, Kosuke Kashiwabara, Kazunori Tobino, Hidenobu Ishii, Yoshihiko Sakata, Megumi Inaba, Kazuhisa Nakashima, Kenji Chibana, Tomoya Fukui, Miiru Izumi, Ryota Saito, Hiroshi Ishii, Shota Omori, Shinsuke Ogusu, Kazuto Furuyama, Satoru Miura, Taishi Harada and Isamu Okamoto
Kyushu University, affiliation not provided to SSRN, Kobe University, Kitakyushu Municipal Medical Center, affiliation not provided to SSRN, affiliation not provided to SSRN, Sendai Kousei Hospital, Kyoto Prefectural University of Medicine, affiliation not provided to SSRN, Kumamoto Regional Medical Center - Department of Respiratory Medicine, Iizuka Hospital, Kurume University - Kurume University Hospital, Saiseikai Kumamoto Hospital, Kumamoto Chuo Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, Shonan Kamakura General Hospital, affiliation not provided to SSRN, Tohoku University - Tohoku University Hospital, Fukuoka University Chikushi Hospital, affiliation not provided to SSRN, Saga University, affiliation not provided to SSRN, Niigata Cancer Center Hospital, affiliation not provided to SSRN and Kyushu University - Kyushu University Hospital
Downloads 145 (521,245)

Abstract:

Loading...

Immune checkpoint inhibitor, Atezolizumab, Carboplatin, nab-paclitaxel, Nonsquamous non-small cell lung cancer